DEA Considers New Importer for Psilocybin and Cannabis
Published Date: 7/7/2026
Notice
Summary
Benuvia Operations, LLC wants to become an official importer of certain controlled substances like marijuana extract and psilocybin. People and companies involved with these drugs can share their thoughts or ask for a hearing by August 6, 2026. This move could shake up who gets to bring these substances into the U.S., so keep an eye on the deadline if you’re interested!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Comment and Hearing Deadline: Aug 6, 2026
Registered bulk manufacturers of the affected drug classes and applicants may submit electronic comments or objections, or file a written request for a hearing, on or before August 6, 2026. Comments must be submitted through https://www.regulations.gov and hearing requests must be sent to the DEA addresses listed in the notice.
Application to Import Specific Controlled Substances
On May 7, 2026, Benuvia Operations, LLC (Round Rock, Texas) applied to be registered as an importer of these basic classes: Marihuana Extract (7350, Schedule I); Psilocybin (7437, Schedule I); Psilocyn (7438, Schedule I); Amphetamine (1100, Schedule II); Lisdexamfetamine (1205, Schedule II); Ecgonine (9180, Schedule II); and Remifentanil (9739, Schedule II). The company plans to import the listed substances as active pharmaceutical ingredients to support its customers.
Import Authorization Limited to APIs — No Finished Dosage Forms
The registration, if approved, will authorize import of the listed substances as active pharmaceutical ingredients (APIs) only; authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. The notice also states that no other activities for these drug codes are authorized for this registration.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20535, Arenbii Pharmacy LLC; Decision and Order
Arenbii Pharmacy in Texas lost its DEA license because it kept filling risky drug prescriptions without fixing obvious problems. This means they can’t legally handle certain controlled medicines anymore, protecting public safety. The decision is final, and Arenbii didn’t ask for a hearing, so the revocation starts now with no chance to appeal.
2026-20553, Decision and Order: Medpharm Research, LLC
Medpharm Research, LLC wanted to get official permission to make marijuana in bulk, but the DEA said no. The DEA found that Medpharm’s related companies were handling marijuana without permission and even selling it for recreational use, which breaks the rules. So, Medpharm’s application was denied, and they can’t legally manufacture marijuana in bulk now.
Previous / Next Documents
Previous: 2026-13704, Certain Flash-Spun Nonwoven Materials and Products Containing Same; Notice of Request for Submissions on the Public Interest
The U.S. International Trade Commission is asking the public and government agencies to share their thoughts on whether certain flash-spun nonwoven materials and products containing them should be blocked from entering the U.S. This comes after a judge suggested these products might be violating trade rules. If blocked, it could affect companies importing or selling these materials, so your input matters before any final decision is made.
Next: 2026-13706, Endangered Species Act; Taking of Endangered and Threatened Species; Permit Modification; Permit No. 23861
The Midwest Biodiversity Institute wants to change its permit to keep studying certain endangered fish like shortnose sturgeon, Atlantic sturgeon, and Atlantic salmon in Maine rivers. This change lets them continue their work while protecting these special fish. People have until August 6, 2026, to share their thoughts, and no new costs or delays are expected.